Funding-round

Octave Bioscience - Series B Extension

CompanyOctave Bioscience
Amount$30,000,000
CurrencyUSD
Announcement date2023-07-26
Round typeSeries B Extension
Primary source urlhttps://www.finsmes.com/2023/07/octave-bioscience-closes-30m-extension-to-series-b-funding.html

Participating investors

CompanyLead
Novartis
Hikma Ventures
The Blue Venture Fund
Echo Health Ventures
Section 32
Northpond Ventures
Deerfield Management
Casdin Capital